New York, September 23 February 2022 /PRNewswire/ — Epiphany Technology Acquisition Corp. (the “Company”) announced today that the Board of Directors of the Company (the “Board”) has approved an increase in the number of directors from seven (7) to eleven (11) directors, and elected Ross Hagerhart, Stephen Sherwin, Ronald Eastman and louis long as a board member. In addition, the Board of Directors appointed Mr. Zhang. Ross Hagerhart Served as the Co-Chief Executive Officer of the Company. The board decides, every Mr. Stephen Sherwin, Ronald Eastman and louis long is an “Independent Director” as defined in the Nasdaq Listing Standards and applicable SEC rules.
While the company may enter into initial business mergers with partner companies in any business or industry, it is initially focused on technology businesses. The public market in general, and the SPAC market in particular, remains challenging, making it difficult for us to work with high-quality tech companies at attractive valuations. We decided to expand our focus to include the biotech industry, which we believe remains a more favorable market environment. To this end, we have increased our management team and board of directors, and hired highly qualified individuals with extensive experience in building, operating and investing in biotech companies.
The Company is a blank check company formed for the purpose of a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.
This press release may contain statements that constitute “forward-looking statements,” including those related to an initial public offering. There can be no assurance that the above offer will be completed on the terms stated, or at all. Forward-looking statements are subject to numerous conditions, many of which are beyond the company’s control, including the risk factors section of the company’s registration statement and those set forth in the offering’s preliminary prospectus filed with the Securities and Exchange Commission. A copy is available on the SEC’s website at www.sec.gov. The company undertakes no obligation to update these statements for revisions or changes after the date of this press release, unless required by law.
Source Epiphany Technology Acquisition Corp